Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care
The current price of BDX is $148.4 USD — it has increased by +0.44% in the past 24 hours. Watch Becton Dickinson stock price performance more closely on the chart.
What is Becton Dickinson stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Becton Dickinson stocks are traded under the ticker BDX.
Is Becton Dickinson stock price growing?▼
BDX stock has risen by +0.9% compared to the previous week, the month change is a -1.3% fall, over the last year Becton Dickinson has showed a -15.04% decrease.
What is Becton Dickinson market cap?▼
Today Becton Dickinson has the market capitalization of 42.26B
When is the next Becton Dickinson earnings date?▼
Becton Dickinson is going to release the next earnings report on July 30, 2026.
What were Becton Dickinson earnings last quarter?▼
BDX earnings for the last quarter are 2.9 USD per share, whereas the estimation was 2.78 USD resulting in a +4.38% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Becton Dickinson revenue for the last year?▼
Becton Dickinson revenue for the last year amounts to 43.68B USD.
What is Becton Dickinson net income for the last year?▼
BDX net income for the last year is 3.36B USD.
Does Becton Dickinson pay dividends?▼
Yes, BDX dividends are paid quarterly. The last dividend per share was 1.05 USD. As of today, Dividend Yield (FWD)% is 2.84%.
How many employees does Becton Dickinson have?▼
As of May 27, 2026, the company has 70,000 employees.
In which sector is Becton Dickinson located?▼
Becton Dickinson operates in the Health & Wellness sector.
When did Becton Dickinson complete a stock split?▼
Becton Dickinson has not had any recent stock splits.
Where is Becton Dickinson headquartered?▼
Becton Dickinson is headquartered in Franklin Lakes, United States.